Brian D. Bradbury, Sc.D.

Affiliations: 
2004 Boston University, Boston, MA, United States 
Area:
Public Health
Google:
"Brian Bradbury"
Cross-listing: PHTree

Parents

Sign in to add mentor
Susan S. Jick grad student 2004 Boston University
 (Antidepressant medications and the risk of breast cancer, and the risk of non-breast cancer outcomes for tamoxifen -treated breast cancer patients.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Muntner P, Hernandez RK, Kent ST, et al. (2024) Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real-world data. Pharmacoepidemiology and Drug Safety. 33: e5770
Levintow SN, Nielson CM, Hernandez RK, et al. (2023) Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses: A narrative review. Pharmacoepidemiology and Drug Safety
Hernandez RK, Nakasian SS, Bollinger L, et al. (2022) Changes in Medication Use During Pregnancy for Women with Chronic Conditions: An Analysis of Claims Data. Therapeutic Innovation & Regulatory Science
Bradbury BD, Lash TL, Kaye JA, et al. (2006) Author reply [2] Cancer. 106: 481
Bradbury BD, Lash TL, Kaye JA, et al. (2005) Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina. Cancer. 103: 1114-21
Bradbury BD, Lash TL, Kaye JA, et al. (2004) Tamoxifen and cataracts: a null association. Breast Cancer Research and Treatment. 87: 189-96
Jick SS, Bradbury BD. (2004) Statins and newly diagnosed diabetes. British Journal of Clinical Pharmacology. 58: 303-9
Kaye JA, Bradbury BD, Jick H. (2003) Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study. British Journal of Clinical Pharmacology. 56: 569-75
Bradbury BD, Jick SS. (2002) Itraconazole and fluconazole and certain rare, serious adverse events. Pharmacotherapy. 22: 697-700
See more...